Curium Pharma Reports - Industry Research
Reports Featuring Curium Pharma
Global Nuclear Medicine Market
The Nuclear Medicine Market is expected to grow significantly at a CAGR of 9.5% during the study period, 2022-2027.
Single Photon Emission Computed Tomography (SPECT) Market
The Single Photon Emission Computed Tomography Market size is estimated at USD 2.23 billion in 2024, and is expected to reach USD 2.60 billion by 2029, growing at a CAGR of 3.20% during the forecast period (2024-2029).
Europe Nuclear Medicine Market
The Europe Nuclear Medicine Market is expected to register a CAGR of 10% during the forecast period.
North America Nuclear Medicine Market
The North America Nuclear Medicine Market size is estimated at USD 3.46 billion in 2024, and is expected to reach USD 4.87 billion by 2029, growing at a CAGR of 7.10% during the forecast period (2024-2029).
Asia-Pacific Nuclear Medicine Market
The Asia-Pacific Nuclear Medicine Market is expected to register a CAGR of 10.0% during the forecast period.
Differentiated Thyroid Cancer Therapeutics Market
The differentiated thyroid cancer (DTC) therapeutics market is expected to register a CAGR of 21.5% during the forecast period.
Other Reports Covering Curium Pharma
Medical Devices
- Africa Nuclear Imaging Market
- Argentina Nuclear Imaging Market
- Canada Nuclear Imaging Market
- China Nuclear Imaging Market
- Europe Nuclear Imaging Market
- France Nuclear Imaging Market
- Germany Nuclear Imaging Market
- Global Diagnostic Radiopharmaceuticals and Contrast Media Market
- India Nuclear Imaging Market
- Italy Nuclear Imaging Market
- Mexico Nuclear Imaging Market
- Middle East and Africa Nuclear Imaging Market
- North America Nuclear Imaging Market
- Nuclear Imaging Market
- Single Photon Emission Computed Tomography (SPECT) Market
- South Africa Nuclear Imaging Market
- Spain Nuclear Imaging Market
- United Kingdom Nuclear Imaging Market
- United States Nuclear Imaging Market
